PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Wendelstein 7-X sets new performance records in nuclear fusion research

World's most powerful stellarator sets record in a key parameter of fusion physics: the triple product

2025-06-03
(Press-News.org) On the path toward a fusion power plant, stellarators are among the most promising concepts. In the future, they could generate usable energy by fusing light atomic nuclei. This reaction must take place in a plasma — a hot gas of ionized particles heated to many tens of millions of degrees Celsius. Stellarators use magnetic confinement to hold the plasma: the plasma is trapped by a complex and powerful magnetic field, floating inside a donut-shaped vacuum chamber. With Wendelstein 7-X (W7-X), the Max Planck Institute for Plasma Physics (IPP) in Greifswald, with support from the European fusion consortium EUROfusion, is operating the world's largest and most powerful experiment of its kind. W7-X is designed to demonstrate that stellarators can, in practice, achieve the outstanding properties predicted by theory – and thus qualify as a concept for future fusion power plants.

World-best triple product for long plasma durations

In the OP 2.3 campaign, which ended on May 22, the international W7-X team achieved a new world record for the triple product in long plasma discharges: on this last day, they sustained a new peak value of this key fusion parameter (see explanation below) for 43 seconds. Wendelstein 7-X thus surpassed the best performances of fusion devices of the tokamak type for longer plasma durations.


Tokamaks also rely on magnetic confinement but are much better studied due to their simpler design. The highest values for the triple product were achieved by the Japanese Tokamak JT60U (decommissioned in 2008) and the European Tokamak facility JET in Great Britain (decommissioned in 2023). With short plasma durations of just a few seconds, they remain the clear front-runners.  In terms of longer plasma durations, which are important for a future power plant, Wendelstein 7-X is now ahead, even though JET had three times the plasma volume. Size makes it much easier to achieve high temperatures in fusion reactors.

"The new record is a tremendous achievement by the international team. It impressively demonstrates the potential of Wendelstein 7-X. Elevating the triple product to tokamak levels during long plasma pulses marks another important milestone on the way toward a power-plant-capable stellarator," says Prof. Dr. Thomas Klinger, Head of Operations at Wendelstein 7-X and Head of Stellarator Dynamics and Transport at IPP.

Key to success: the new pellet injector from Oak Ridge National Laboratory

The new triple product world record for long pulses was made possible by the close collaboration between the European Wendelstein 7-X team in Greifswald and partners from the USA. A key role was played by the new pellet injector (more details at the end of this article), which injects frozen hydrogen pellets into the plasma, enabling long plasma durations through continuous refueling. The U.S. Department of Energy’s (DOE) Oak Ridge National Laboratory (ORNL) in Tennessee developed this highly sophisticated and globally unique injector and successfully put it into operation at Wendelstein 7-X.

During the record-setting experiment, about 90 frozen hydrogen pellets, each about a millimeter in size, were injected over 43 seconds, while powerful microwaves simultaneously heated the plasma. Precise coordination between heating and pellet injection was crucial to achieve the optimal balance between heating power and fuel supply. The key was operating the pellet injector with variable pre-programmed pulse rates for the first time — a scheme executed with impressive precision. This method is directly relevant for future fusion reactors and can potentially extend plasma durations to several minutes.

The use of pellets was made possible thanks to preliminary work carried out by several European laboratories, including simulation calculations by the Centre for Energy, Environmental and Technological Research (CIEMAT) in Spain and observations using ultra-fast cameras by the HUN-REN Centre for Energy Research in Budapest. The microwave heating system (more precisely: electron cyclotron resonance) was developed in collaboration with the Karlsruhe Institute of Technology (KIT) and a team from the University of Stuttgart. It is considered the most promising method for bringing plasma to temperatures relevant for fusion.

In the record-breaking experiment, the plasma temperature was raised to over 20 million degrees Celsius, reaching a peak of 30 million degrees. Measurements to calculate the triple product were provided, among others, by Princeton Plasma Physics Laboratory, which operates an X-ray spectrometer for ion temperature diagnostics at W7-X. The necessary electron density data came from IPP's worldwide unique interferometer. The energy confinement time required for the triple product calculation was also determined using diagnostic tools developed at IPP.

Additional highlights from the OP 2.3 campaign

During the OP 2.3 experimental campaign, Wendelstein 7-X achieved two further milestones:

Energy turnover was increased to 1.8 gigajoules (plasma duration: 360 seconds).
The previous record from February 2023 was 1.3 gigajoules. Energy turnover is calculated as the product of injected heating power and plasma duration.
Maintaining continuous high-energy input and removing the generated heat are prerequisites for future power plant operation. The corresponding best value for the 1000-second discharge in the Tokamak EAST (China) was even slightly exceeded by Wendelstein 7-X. Plasma pressure relative to magnetic pressure reached 3% for the first time across the full plasma volume. In a dedicated experiment series, the magnetic field was deliberately reduced to about 70%, lowering magnetic pressure and allowing plasma pressure to rise. This ratio is a key parameter for extrapolating to a fusion power plant, where 4–5% across the volume will be needed. The new record value was accompanied by a peak ion temperature of around 40 million degrees Celsius. Prof. Dr. Robert Wolf, Head of Stellarator Heating and Optimization at IPP, summarizes:
"The records of this experimental campaign are much more than mere numbers. They represent a significant step forward in validating the stellarator concept — made possible through outstanding international collaboration."

 

More information about the triple product

The triple product — also known as the Lawson criterion — is the key metric for success on the path to a fusion power plant. Only when a certain threshold is exceeded can a plasma produce more fusion power than the heating power invested. This marks the point where the energy balance becomes positive, and the fusion reaction can sustain itself without continued external heating.

For a fusion power plant, the required threshold is:

n∙T∙???? = 3 × 10²¹ m⁻³ keV s

The triple product is derived from three factors:

the particle density of the plasma n, its temperature T (more precisely: the temperature of the ions between which fusion reactions take place) and the energy confinement time ???? (pronounced: tau), i.e. the time it takes for the thermal energy to escape from the plasma if no additional heat is supplied. The confinement time is therefore a measure of the thermal insulation. More information about the pellet injector

Since September 2024, the new continuously operating pellet injector has been successfully in use.
It was developed at Oak Ridge National Laboratory, a research center of the U.S. Department of Energy, specifically for Wendelstein 7-X, and it sets a global benchmark in its category.
The pellet injector ensures a steady supply of hydrogen particles into the plasma — a crucial requirement for future fusion power plants.

The device continuously forms a 3-millimeter-diameter strand of frozen hydrogen, from which 3.2-millimeter-long cylindrical pellets are cut at intervals of fractions of a second and fired into the plasma at speeds of 300 to 800 meters per second.

END



ELSE PRESS RELEASES FROM THIS DATE:

Brain connections at 3 months predict infant emotional development

2025-06-03
PITTSBURGH, Pennsylvania, USA, 3 June 2025 – In a comprehensive Genomic Press research article, scientists have uncovered remarkable insights into how the earliest brain connections shape infant emotional development, potentially offering new ways to identify children at risk for future behavioral and emotional challenges. The groundbreaking study, led by Dr. Yicheng Zhang and Dr. Mary L. Phillips at the University of Pittsburgh School of Medicine, examined 95 infant-caregiver pairs using advanced brain imaging techniques. Researchers discovered that the microstructure of white matter ...

Listening to life: Speech technology transforms clinical research

2025-06-03
ATLANTA, Georgia, USA, 3 June 2025 – In a comprehensive Genomic Press interview published today in Psychedelics, Dr. Deanna M. Kaplan reveals how her journey from journalism student to clinical psychologist led to revolutionary advances in capturing human experiences through voice technology. As Assistant Professor at Emory University School of Medicine and Director of Health Technologies for Spiritual Health at Emory Healthcare, Dr. Kaplan has transformed how researchers understand the impact of clinical ...

ECT sessions shape depression treatment outcomes

2025-06-03
HEFEI, Anhui, China, 3 June 2025 – In a comprehensive peer-reviewed Genomic Press Thought Leaders Invited Review, researchers have unveiled critical insights into how the number of electroconvulsive therapy (ECT) sessions influences treatment outcomes for depression, potentially transforming clinical decision-making for one of psychiatry's most effective yet controversial treatments. The review, published in Brain Medicine, synthesizes decades of research to address a fundamental question that has long puzzled clinicians: How many ECT sessions are optimal for treating severe depression while minimizing cognitive side effects? "ECT is like a powerful ...

Psilocybin enters gastroenterology: First-ever psychedelic study targets treatment-resistant IBS

2025-06-03
BOSTON, Massachusetts, USA, 3 June 2025 – In a comprehensive Genomic Press Interview published today, Dr. Erin E. Mauney reveals how her pioneering research brings psychedelic medicine into gastroenterology for the first time, potentially transforming treatment for millions suffering from intractable irritable bowel syndrome (IBS). The assistant professor of pediatrics at Tufts University, who maintains a research appointment at Massachusetts General Hospital, leads the first clinical trial examining psilocybin's effects on treatment-resistant IBS. Her work addresses a critical gap in medicine: the substantial population ...

Renowned psychiatrist illuminates biological roots of mental illness through pioneering research

2025-06-03
MILANO, Italy, 3 June 2025 – In a comprehensive Genomic Press Interview published in Brain Medicine, Professor Francesco Benedetti shares his transformative journey from confronting childhood awareness of mental illness to becoming a leading figure in psychiatric research. As founder and leader of the Psychiatry & Clinical Psychobiology research unit at IRCCS Ospedale San Raffaele, Dr. Benedetti has dedicated decades to reclaiming psychiatry's rightful place within medical science. Professor ...

Ancient collagen can help identify a “wombat the size of a hippo” in the fossil record

2025-06-03
What happened to all the megafauna? From moas to mammoths, many large animals went extinct between 50 and 10,000 years ago. Learning why could provide crucial evidence about prehistoric ecosystems and help us understand future potential extinctions. But surviving fossils are often too fragmented to determine the original species, and DNA is not always recoverable, especially in hot or damp environments. Now scientists have isolated collagen peptide markers which allow them to identify three key megafauna ...

Being in nature can help people with chronic back pain manage their condition

2025-06-03
ing time in or around nature can provide people suffering from chronic lower back pain with a degree of escapism that helps them better manage their physical discomfort, a new study has shown. The research, published in The Journal of Pain, is the first of its kind to ask people experiencing chronic lower back pain – in some cases for almost 40 years – about the role nature plays in any coping strategies they employ to help manage their condition. The researchers found that people able to get out in nature said it enabled them to connect with ...

Eating rate has sustained effects on energy intake from ultra-processed diets, new study reveals

2025-06-03
Brussels, Belgium — 2 June 2025 — A randomized controlled trial (RCT) carried out by researchers from Wageningen University, the Netherlands, has provided new evidence that texture-derived differences in meal eating rate influence energy intake from diets composed of ultra-processed foods (UPFs). Over a 14-day period, participants consuming a UPF diet with textures that reduced their eating rate, had an average energy intake reduction of 369 kcal per day, compared to when they followed a 14-day UPF diet with textures that promoted a faster ...

Rise in expectant mothers in UK with autoimmune diseases since millennium

2025-06-02
Thousands more UK women who are having children have been diagnosed with an autoimmune condition now compared to the beginning of the millennium. In a paper published in Lancet Rheumatology today, researchers involved in the MuM-PreDiCT project run by the University of Birmingham and funded by the Medical Research Council have found that there has been increase by 4.7% in expectant mothers beginning pregnancy with autoimmune conditions. Analysis of electronic healthcare records (CPRD) taken from 2000-2021 found that there was a ...

Majority of riders and drivers in UK 'gig economy' suffer anxiety over ratings and pay, study suggests

2025-06-02
Some two-thirds of riders and drivers for food delivery and ride-hailing apps in the UK may work in fear of “unfair feedback” and experience anxiety over sudden changes to working hours, a new survey study led by the University of Cambridge suggests.* Three-quarters of riders and drivers in the study report anxiety over potential for income to drop, with over half (51%) saying they risk health and safety while working. Some 42% of delivery and driver gig workers say they suffer physical pain resulting from work. Riders ...

LAST 30 PRESS RELEASES:

Following the tracks of an extremely adaptive bacterium

New ‘designer drugs’ pose growing threat to road safety in the US

Tackling depressive symptoms in high school students by honing emotional and social skills

One in five US foods and drinks contain synthetic dyes, study shows

One in five packaged foods and drinks sold in the United States contains synthetic dyes, study shows

Large global study links severe bleeding after childbirth to increased risk of cardiovascular disease

Breaking the silence about men breaking bones

More sex, less pain and irritation for perimenopausal and postmenopausal women

New review highlights histone and non-histone lysine lactylation: From molecular mechanisms to therapeutic frontiers

Boson sampling finds first practical applications in quantum AI

Add a twist to π-molecules! A new design strategy for organic semiconductor materials

Bushfire evacuation simulator wins prestigious US prize

Desert lichen offers new evidence for the possibility of life on other planets

Researchers reveal how brain amplifies perception of pain from multiple sources

The first “SpongeBooster of the Year” award celebrates efforts in wetland restoration

AI innovation at UBC Okanagan helps shipping ports see what’s coming—literally

Autoimmune disease linked to doubling in depression, anxiety, bipolar risks

Emotional demands and confrontation in person-contact roles linked to heightened type 2 diabetes risk

UK annual cost of dog walkers’ hand/wrist injuries estimated to top £23 million

The Lancet: Life-saving childhood vaccination coverage has stalled in recent decades, leaving millions of children at risk for deadly diseases

MD Anderson achieves sixth Magnet designation in recognition of nursing excellence

A unified theory of the mind

UTA powers smarter microgrids with new converter tech

US$53,000 essay competition asks: "How Quantum is Life?"

New combination therapy for rheumatoid arthritis: Targeting M6A methylation pathways

Editorial for the special issue on carbon capture, utilization, and storage

'A more versatile and powerful foundation for future photonic technologies'

World’s soft coral diversity retains signature of an ancient, vanished sea

Scientists use gene editing to correct harmful mitochondrial mutations in human cells

The evolution from reptile-like to upright posture in mammals was highly dynamic and complex

[Press-News.org] Wendelstein 7-X sets new performance records in nuclear fusion research
World's most powerful stellarator sets record in a key parameter of fusion physics: the triple product